These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4777608

  • 41. Effect of formulation and process variables on bioequivalency of nitrofurantoin II: in vivo-in vitro correlation.
    Mendes RW, Masih SZ, Kanumuri RR.
    J Pharm Sci; 1978 Nov; 67(11):1616-9. PubMed ID: 712603
    [Abstract] [Full Text] [Related]

  • 42. In vivo/in vitro correlation regarding nitrofurantoin tablets.
    Munoz Carnago E, Gonzales Porto E.
    Pharmazie; 1986 Apr; 41(4):290-1. PubMed ID: 3725877
    [No Abstract] [Full Text] [Related]

  • 43. The pharmacokinetics of nitrofurantoin and its related bioavailability.
    Conklin JD.
    Antibiot Chemother (1971); 1978 Apr; 25():233-52. PubMed ID: 352255
    [Abstract] [Full Text] [Related]

  • 44. On the effect of pharmaceutical formulation on thioridazine absorption.
    Hirst CA, Kaye RC.
    J Pharm Pharmacol; 1971 Dec; 23():246S-247S. PubMed ID: 4401505
    [No Abstract] [Full Text] [Related]

  • 45. Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.
    Vogelpoel H, Welink J, Amidon GL, Junginger HE, Midha KK, Möller H, Olling M, Shah VP, Barends DM.
    J Pharm Sci; 2004 Aug; 93(8):1945-56. PubMed ID: 15236445
    [Abstract] [Full Text] [Related]

  • 46. Single-dose pharmacokinetics of macrocrystalline nitrofurantoin formulations.
    Liedtke RK, Ebel S, Missler B, Haase W, Stein L.
    Arzneimittelforschung; 1980 Aug; 30(5):833-6. PubMed ID: 7190430
    [Abstract] [Full Text] [Related]

  • 47. Physiological and pharmacokinetic complexities in bioavailability testing.
    Riegelman S.
    Pharmacology; 1972 Aug; 8(1):118-41. PubMed ID: 4644643
    [No Abstract] [Full Text] [Related]

  • 48. Effect of propantheline on nitrofurantoin absorption.
    Jaffe JM.
    J Pharm Sci; 1975 Oct; 64(10):1729-30. PubMed ID: 1185550
    [No Abstract] [Full Text] [Related]

  • 49. Bioavailability studies of acetaminophen and nitrofurantoin.
    Albert KS, Sedman AJ, Wilkinson P, Stoll RG, Murray WJ, Wagner JG.
    J Clin Pharmacol; 1974 Oct; 14(5-6):264-70. PubMed ID: 4829520
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. A comparative study on the excretion and metabolic degradation of nitrofurantoin and analogues.
    Holmen-Christensen H, Andersen HO.
    Acta Pharmacol Toxicol (Copenh); 1967 Oct; 25():Suppl 4:50. PubMed ID: 5630945
    [No Abstract] [Full Text] [Related]

  • 53. Age-dependence of renal tubular reabsorption of nitrofurantoin.
    Bräunlich H, Bonow A, Schröter S.
    Arch Int Pharmacodyn Ther; 1978 Mar; 232(1):92-101. PubMed ID: 27154
    [Abstract] [Full Text] [Related]

  • 54. [In vitro and in vivo investigations with different nitrofurantoin formulations (author's transl)].
    Gladigau V, Gebhardt U.
    Arzneimittelforschung; 1978 Mar; 28(10):1771-8. PubMed ID: 582682
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Bioavailability of digoxin tablets.
    Lindenbaum J.
    Pharmacol Rev; 1973 Jun; 25(2):229-37. PubMed ID: 4581042
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Cross-over study of ten tetracycline preparations.
    Tuomisto J, Männistö P.
    Eur J Clin Pharmacol; 1973 Jun; 6(1):64-8. PubMed ID: 4587517
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.